All News

These are the powerful stories of real-life heroes in the lung cancer space who persevere with great compassion and teach us to embrace, not avoid, life’s setbacks and challenges.

"Dr. Hossein came to the United States by himself in his teens as a political refugee from the turmoil in Iran," writes a colleague who nominated him for the Lung Cancer Heroes® Award. "Completely on his own and through his hard work, scholarship, initiative and refusal to let things get him down, he went to college and then to medical school."

The Food and Drug Administration approved Scemblix for patients with Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase whose disease progressed on prior TKI treatment.

Study results showed that CPI-613 did not improve survival in patients with metastatic adenocarcinoma of the pancreas.

Attention to detail is important for cancer survivors, explains a male breast cancer survivor. “Asking guys to examine their ‘chests’ is not only ineffective, but also disingenuous.”

From the death of “Friends” actor James Michael Tyler to Sally Yates’ breast cancer announcement, here’s what’s happening in the cancer landscape this week.

CURE®’s Lung Cancer Heroes® Award Program celebrates and thanks the heroes who make a difference in the lives of patients with lung cancer.

Cleveland Clinic’s Lerner Research Institute has initiated a new study to examine a vaccine to prevent triple-negative breast cancer.

Although being in a close relationship during the cancer journey can dramatically improve outcomes, the stress of treatment and the diagnosis itself can take a toll on couples, sometimes in a negative way.

Kymriah was granted a priority review for the treatment of pretreated patients with relapsed or refractory follicular lymphoma.

“The financial burden is another gift that cancer keeps on giving,” writes the mother and caregiver of a young woman with breast cancer.

On this episode of the “Cancer Horizons” podcast, CURE® contributor Amanda Ferraro describes what it was like to receive a cancer diagnosis at 28 years old with a 3-year-old child and discusses the importance of mental health for cancer survivors.

Some patients with small kidney tumors may be able to forego treatment and have regular medical checkups instead.

An intervention strategy focused on goal pursuit and skill building may be the ticket to helping reduce high emotional distress levels experienced by young adult survivors of testicular cancer.

Memory, attention and the ability to multitask may be affected in patients with lymphoma during and after chemotherapy treatment, which can impact one’s capability to complete daily tasks.

When you’re forced into menopause at an early age, you aren’t as prepared for the changes it brings. A woman with metastatic breast cancer explains the difficulties of medically induced menopause.

When a patient’s cancer spreads to the brain, their original cancer type may predict what region of the brain the metastasis occurs in, according to new findings. The research could lead to better treatment approaches in the future.

Women with a myeloproliferative neoplasm can have healthy pregnancies, as long as they coordinate their care and know what to look out for.

A phase 1b trial started to study the effects of fosciclopirox in patients with newly diagnosed and recurrent bladder cancer.

The rate of treatment discontinuation with Soltamox increased from 15.8% at one year after breast cancer diagnosis to 48.3% at five years, although more research is needed into why this is occurring.

Medically underserved and minority breast cancer survivors experienced improved outcomes and quality of life after participating in community-based physical activity programs, according to recent study results.

Even in the doctor’s office, the words patients hear can cover up the realities of stage 4 breast cancer. “He thought he was offering hope but what he was doing was denying my reality and minimizing the deaths of so many people,” writes a woman with metastatic breast cancer.

Treatment with the immunotherapy Opdivo for relapsed, malignant mesothelioma may represent a useful choice for patients with minimal therapy options.

New research in blood cancer includes new treatment options for acute myeloid leukemia and a novel therapy using BK virus-specific T cells to treat BK virus-associated hemorrhagic cystitis.

“When survival became my identity, things began to shift in my life forever,” writes a blood cancer survivor.

Dr. Gabriela Hobbs offers insight into a rare cancer, myeloproliferative neoplasms, to help patients learn more during their treatment journey.

Dr. Ami P. Vaidya tells patients and their loved ones what to expect when they opt for cancer genetic testing.

A women describes how the difficulties of stage 0 breast cancer is still misunderstood by many.

More than 10 years of follow-up data have shown that combining Herceptin with chemotherapy is safer and more effective than chemotherapy alone in this patient population.

When a patient’s disease stops responding, doctors can usually offer patients several options for a next treatment that will accommodate the patient’s needs and goals, or patients can consider a clinical trial.